Fidaxomicin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Created page with "{{subpages}} In infection disease, '''fidaxomicin''' is an macrocyclide antibiotic. It may be used to treat Pseudomembranous enterocolitis caused by [[clostridium dif...") |
imported>Robert Badgett mNo edit summary |
||
| Line 2: | Line 2: | ||
In [[infection disease]], '''fidaxomicin''' is an macrocyclide [[antibiotic]]. | In [[infection disease]], '''fidaxomicin''' is an macrocyclide [[antibiotic]]. | ||
It may be used to treat [[Pseudomembranous enterocolitis]] caused by [[clostridium difficile]] infection. | It may be used to treat [[Pseudomembranous enterocolitis]] caused by [[clostridium difficile]] infection. | ||
==History== Dificid brand of fidaxomicin was approved for Optimer Pharms by the [[Food and Drug Administration]] in the [[United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2011.<ref>{{FDA-Drug_Details|201699}}</ref> | |||
==History== | |||
Dificid brand of fidaxomicin was approved for Optimer Pharms by the [[Food and Drug Administration]] in the [[United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2011.<ref>{{FDA-Drug_Details|201699}}</ref> | |||
==Pharmacology== | |||
===Administration=== | |||
===Distribution=== | |||
===Metabolism=== | |||
===Excretion=== | |||
===Toxicity=== | |||
[[Drug toxicity]] includes | |||
==External links== | |||
{{CZMed}} | |||
==References== | |||
<references/> | |||
Revision as of 11:38, 8 August 2011
In infection disease, fidaxomicin is an macrocyclide antibiotic. It may be used to treat Pseudomembranous enterocolitis caused by clostridium difficile infection.
History
Dificid brand of fidaxomicin was approved for Optimer Pharms by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 2011.[1]
Pharmacology
Administration
Distribution
Metabolism
Excretion
Toxicity
Drug toxicity includes
External links
The most up-to-date information about Fidaxomicin and other drugs can be found at the following sites.
- Fidaxomicin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Fidaxomicin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Fidaxomicin - Detailed information from DrugBank.
References
- ↑ Anonymous. Drugs@FDA for FDA Application No. 201699. U S Food and Drug Administration